E-blast download link generator
The 2019 communication at ASCO from the French Unicancer group confirmed the Clinical relevance the strategy of p4EBP1 staining to predict clinical benefit of everolimus in HR+ HER2- Breast Cancer. Since the beginning, OncoDNA included a unique combination and integration of different biomarkers by NGS and IHC analysis through its molecular profiling solution OncoDEEP and OncoSTRAT&GO.
Biomarkers to predict clinical response to mTOR inhibitors
Generate your download link